Interrupt Labs Limited 13427173 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is the provision of cyber security services. Digita Accounts Production Advanced 6.30.9574.0 true true true Class 1 Class 2 Class 3 false false true true false false false 13427173 2025-01-01 2025-12-31 13427173 2025-12-31 13427173 bus:OrdinaryShareClass1 2025-12-31 13427173 bus:OrdinaryShareClass2 2025-12-31 13427173 bus:OrdinaryShareClass3 2025-12-31 13427173 core:CapitalRedemptionReserve 2025-12-31 13427173 core:RetainedEarningsAccumulatedLosses 2025-12-31 13427173 core:ShareCapital 2025-12-31 13427173 core:CurrentFinancialInstruments 2025-12-31 13427173 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 13427173 core:Non-currentFinancialInstruments 2025-12-31 13427173 core:Non-currentFinancialInstruments core:AfterOneYear 2025-12-31 13427173 core:AdditionsToInvestments 2025-12-31 13427173 core:CostValuation 2025-12-31 13427173 core:FurnitureFittingsToolsEquipment 2025-12-31 13427173 core:OtherProvisionsContingentLiabilities 2025-12-31 13427173 bus:FRS102 2025-01-01 2025-12-31 13427173 bus:Audited 2025-01-01 2025-12-31 13427173 bus:FullAccounts 2025-01-01 2025-12-31 13427173 bus:RegisteredOffice 2025-01-01 2025-12-31 13427173 bus:Director1 2025-01-01 2025-12-31 13427173 bus:Director2 2025-01-01 2025-12-31 13427173 bus:Director3 2025-01-01 2025-12-31 13427173 bus:Director4 2025-01-01 2025-12-31 13427173 bus:HighestPaidDirector 2025-01-01 2025-12-31 13427173 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 13427173 bus:OrdinaryShareClass2 2025-01-01 2025-12-31 13427173 bus:OrdinaryShareClass3 2025-01-01 2025-12-31 13427173 bus:Consolidated 2025-01-01 2025-12-31 13427173 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 13427173 bus:Agent1 2025-01-01 2025-12-31 13427173 core:CapitalRedemptionReserve 2025-01-01 2025-12-31 13427173 core:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 13427173 core:ShareCapital 2025-01-01 2025-12-31 13427173 countries:UnitedKingdom 2025-01-01 2025-12-31 13427173 core:ReportableOperatingSegment1 2025-01-01 2025-12-31 13427173 core:ReportableOperatingSegment2 2025-01-01 2025-12-31 13427173 core:ReportableOperatingSegment3 2025-01-01 2025-12-31 13427173 core:ComputerEquipment 2025-01-01 2025-12-31 13427173 core:FurnitureFittingsToolsEquipment 2025-01-01 2025-12-31 13427173 core:LeaseholdImprovements 2025-01-01 2025-12-31 13427173 core:OfficeEquipment 2025-01-01 2025-12-31 13427173 core:Subsidiary1 2025-01-01 2025-12-31 13427173 core:Subsidiary1 1 2025-01-01 2025-12-31 13427173 core:Subsidiary1 countries:England 2025-01-01 2025-12-31 13427173 core:Subsidiary2 2025-01-01 2025-12-31 13427173 core:Subsidiary2 1 2025-01-01 2025-12-31 13427173 core:Subsidiary2 countries:England 2025-01-01 2025-12-31 13427173 core:Subsidiary3 2025-01-01 2025-12-31 13427173 core:Subsidiary3 1 2025-01-01 2025-12-31 13427173 core:Subsidiary3 countries:AllCountries 2025-01-01 2025-12-31 13427173 core:Subsidiary4 2025-01-01 2025-12-31 13427173 core:Subsidiary4 1 2025-01-01 2025-12-31 13427173 core:Subsidiary4 countries:Australia 2025-01-01 2025-12-31 13427173 core:UKTax 2025-01-01 2025-12-31 13427173 1 2025-01-01 2025-12-31 13427173 countries:England 2025-01-01 2025-12-31 13427173 2024-12-31 13427173 core:CapitalRedemptionReserve 2024-12-31 13427173 core:RetainedEarningsAccumulatedLosses 2024-12-31 13427173 core:ShareCapital 2024-12-31 13427173 core:CostValuation 2024-12-31 13427173 core:FurnitureFittingsToolsEquipment 2024-12-31 13427173 core:OtherProvisionsContingentLiabilities 2024-12-31 13427173 2024-01-01 2024-12-31 13427173 2024-12-31 13427173 bus:OrdinaryShareClass1 2024-12-31 13427173 bus:OrdinaryShareClass2 2024-12-31 13427173 bus:OrdinaryShareClass3 2024-12-31 13427173 core:CurrentFinancialInstruments 2024-12-31 13427173 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 13427173 core:Non-currentFinancialInstruments 2024-12-31 13427173 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 13427173 core:FurnitureFittingsToolsEquipment 2024-12-31 13427173 bus:HighestPaidDirector core:PreviouslyStatedAmount 2024-01-01 2024-12-31 13427173 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 13427173 core:ShareCapital 2024-01-01 2024-12-31 13427173 countries:UnitedKingdom core:PreviouslyStatedAmount 2024-01-01 2024-12-31 13427173 core:PreviouslyStatedAmount 2024-01-01 2024-12-31 13427173 core:Subsidiary1 1 2024-01-01 2024-12-31 13427173 core:Subsidiary2 1 2024-01-01 2024-12-31 13427173 core:Subsidiary3 1 2024-01-01 2024-12-31 13427173 core:Subsidiary4 1 2024-01-01 2024-12-31 13427173 core:UKTax 2024-01-01 2024-12-31 13427173 2023-12-31 13427173 core:RetainedEarningsAccumulatedLosses 2023-12-31 13427173 core:ShareCapital 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 13427173

Interrupt Labs Limited

Annual Report and Financial Statements

for the Year Ended 31 December 2025

 

Interrupt Labs Limited

Contents

Company Information

1

Strategic Report

2 to 5

Directors' Report

6

Statement of Directors' Responsibilities

7

Independent Auditor's Report

8 to 11

Profit and Loss Account

12

Balance Sheet

13

Statement of Changes in Equity

14

Notes to the Financial Statements

15 to 27

 

Interrupt Labs Limited

Company Information

Directors

J Loureiro

A Last

S Heath

P Taylor

Registered office

Matrix House
Basing View
Basingstoke
Hampshire
RG21 4FF

Auditors

RSM UK Audit LLP
Chartered AccountantsDavidson House
Forbury Square
Reading
Berkshire
RG1 3EU

 

Interrupt Labs Limited

Strategic Report for the Year Ended 31 December 2025

The directors present their strategic report for the year ended 31 December 2025.

Principal activity

The principal activity of the Company was the provision of cyber security services.

Review of the business

Financial Performance

The Company continued to deliver revenue growth during the year alongside an improvement in gross margin and operating performance. Since commencement of trading in 2022, the business has achieved a compound annual growth rate of approximately 26%, reflecting continued demand for its services and investment in world leading talent and capabilities.

Investment and Financial Position

The Company’s balance sheet reflects the strong trading performance to date, and this is expected to strengthen further in 2026. Management continues to monitor liquidity and funding requirements closely as part of its regular financial oversight processes.

Overall Performance

Continued investment in people, capabilities and market expansion places the Company in a strong position to pursue sustainable and profitable growth in future periods.

Principal risks and uncertainties

The Board is responsible for identifying, evaluating and managing the principal risks faced by the Company. Risk management forms part of the Company’s ongoing strategic planning and operational oversight processes. The principal risks and uncertainties currently considered to have the potential to impact the Company’s performance are set out below, together with the key mitigation measures in place.

Interest Rate Risk

The Company utilises variable rate borrowing to support internal investment activities and working capital requirements. As a result, the Company is exposed to movements in interest rates, with debt facilities linked to the Bank of England base rate.

Changes in interest rates may increase finance costs and place pressure on cash flows and profitability. While current market expectations indicate relative stability in the near term, macroeconomic uncertainty may result in unexpected rate movements.

Mitigation

The Board monitors interest rate exposure as part of its regular financial review processes, including forecasting and sensitivity analysis. Borrowing levels are maintained at prudent levels relative to earnings and cash generation, and the Company retains flexibility within its financial planning to manage potential increases in financing costs.

 

Interrupt Labs Limited

Strategic Report for the Year Ended 31 December 2025

Inflationary Pressure

The Company may be exposed to inflationary pressures where customer contracts are agreed on fixed-fee arrangements that are not directly index-linked. Sustained increases in salary costs or operating expenses could therefore impact margins if not reflected in pricing.

Mitigation

Management considers inflation assumptions when setting pricing structures and preparing financial forecasts. Contract pricing is reviewed regularly, and new engagements are priced to reflect prevailing market conditions.

Employee Recruitment and Retention

As a people-based business, the Company’s performance depends significantly on its ability to attract, develop and retain skilled talent. A competitive labour market, particularly for experienced professionals, may create challenges in recruitment or increase employment costs.

Mitigation

The Company seeks to maintain a supportive and inclusive working environment aligned with its ESG commitments. Key initiatives include:

investment in training and professional development;
competitive and appropriately benchmarked remuneration and benefits;
flexible and hybrid working arrangements;
active focus on employee wellbeing and engagement; and
regular employee feedback processes supported by transparent communication from management.

The Board monitors workforce stability and engagement as part of its ongoing operational oversight.

Information Security and Data Protection

The Company handles commercially sensitive information as part of its activities and is therefore exposed to risks associated with cyber security incidents, data loss or unauthorised access to systems.
A significant data breach could result in operational disruption, reputational damage and potential regulatory consequences.

Mitigation

The Company maintains IT systems and infrastructure designed to meet high security standards, supported by externally hosted environments and specialist providers.

Economic and Market Conditions

Demand for research services may be influenced by broader economic conditions and customer investment cycles. Periods of economic uncertainty may result in delayed customer decision-making or reduced discretionary spending.

 

Interrupt Labs Limited

Strategic Report for the Year Ended 31 December 2025

Mitigation

The Company maintains regular financial forecasting processes to enable timely management responses. The diversity of the Company’s service offerings and platform teams provides a degree of resilience against fluctuations in individual markets.

Key performance indicators

The Board monitors a range of financial and operational key performance indicators (“KPIs”) to assess the Company’s performance against its strategic objectives. The KPIs applied have evolved alongside the Company’s development, reflecting the transition from an early-stage growth business to a focus on sustainable and profitable expansion.

Revenue Growth

Historically, revenue growth has been the principal KPI, reflecting its early-stage expansion strategy and objective of establishing a leading position within the UK market.

Revenue increased to £11.8 million for the year ended 31 December 2025, demonstrating significant growth since inception. Having now achieved substantial market penetration, the strategic focus is transitioning from rapid expansion toward sustainable and profitable growth.

The Board continues to monitor revenue growth as a key indicator of market demand and competitive positioning, while placing increasing emphasis on margin quality and operational efficiency.

Gross Margin and Profitability

As the Company matures, improvement in gross margin and overall profitability has become a primary performance focus. The Board considers gross margin to be a key indicator of operational discipline, pricing effectiveness and scalability of service delivery.

Future performance will therefore be assessed not only on revenue growth but also on the ability to enhance margins while maintaining service quality and client satisfaction.

Outlook and KPI Evolution

The Board expects the Company’s KPI framework to continue evolving as the business matures. Future performance measurement will increasingly emphasise:

sustainable revenue growth;
gross margin expansion;
cash generation and balance sheet resilience; and
achievement of self-sustaining international operations.

These measures are intended to support the Company’s objective of delivering long-term, profitable growth while maintaining operational discipline and resilience.

Approved and authorised by the Board on 6 May 2026 and signed on its behalf by:
 

 

Interrupt Labs Limited

Strategic Report for the Year Ended 31 December 2025

.........................................
J Loureiro
Director

 

Interrupt Labs Limited

Directors' Report for the Year Ended 31 December 2025

The directors present their report and the financial statements for the year ended 31 December 2025.

Principal activity

The principal activity of the Company was the provision of cyber security services.

Results and dividends

The results for the year are set out on page 12.

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

Directors of the Company

The directors who held office during the year were as follows:

J Loureiro

A Last

S Heath

P Taylor

Disclosure of information to the auditors

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the Company's auditor is unaware. Additionally, each director has taken all the necessary steps that they ought to have taken as a director in order to make themselves aware of all relevant audit information and to establish that the Company's auditor is aware of that information.
 

Auditor

The auditor, RSM UK Audit LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Approved and authorised by the Board on 6 May 2026 and signed on its behalf by:
 

.........................................
J Loureiro
Director

 

Interrupt Labs Limited

Statement of Directors' Responsibilities

The directors acknowledge their responsibilities for preparing the Strategic Report and the Directors Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Interrupt Labs Limited

Independent Auditor's Report to the Members of Interrupt Labs Limited

Opinion

We have audited the financial statements of Interrupt Labs Limited (the 'Company') for the year ended 31 December 2025, which comprises the Profit and Loss Account, Balance Sheet, Statement of Changes in Equity, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the Company's affairs as at 31 December 2025 and of its profit for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements were authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

 

Interrupt Labs Limited

Independent Auditor's Report to the Members of Interrupt Labs Limited

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page 7, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.

Auditor Responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

 

Interrupt Labs Limited

Independent Auditor's Report to the Members of Interrupt Labs Limited

The extent to which our procedures are capable of detecting irregularities, including fraud

Irregularities are instances of non-compliance with laws and regulations. The objectives of our audit are to obtain sufficient appropriate audit evidence regarding compliance with laws and regulations that have a direct effect on the determination of material amounts and disclosures in the financial statements, to perform audit procedures to help identify instances of non-compliance with other laws and regulations that may have a material effect on the financial statements, and to respond appropriately to identified or suspected non-compliance with laws and regulations identified during the audit.

In relation to fraud, the objectives of our audit are to identify and assess the risk of material misstatement of the financial statements due to fraud, to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud through designing and implementing appropriate responses and to respond appropriately to fraud or suspected fraud identified during the audit.

However, it is the primary responsibility of management, with the oversight of those charged with governance, to ensure that the entity's operations are conducted in accordance with the provisions of laws and regulations and for the prevention and detection of fraud.

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud, the audit engagement team:

obtained an understanding of the nature of the industry and sector, including the legal and regulatory framework that the company operates in and how the company is complying with the legal and regulatory framework;

inquired of management, and those charged with governance, about their own identification and assessment of the risks of irregularities, including any known actual, suspected or alleged instances of fraud;

discussed matters about non-compliance with laws and regulations and how fraud might occur including assessment of how and where the financial statements may be susceptible to fraud.

 

As a result of these procedures, we consider the most significant laws and regulations that have a direct impact on the financial statements are FRS 102, the Companies Act 2006 and tax compliance regulations. We performed audit procedures to detect non-compliances which may have a material impact on the financial statements which included reviewing financial statement disclosures, inspecting correspondence with local tax authorities and evaluating advice received from external tax advisors.

 

The audit engagement team identified the risk of management override of controls and revenue cut-off as the areas where the financial statements were most susceptible to material misstatement due to fraud. Audit procedures performed included but were not limited to testing high risk journal entries and other adjustments made in the preparation of the financial statements, and evaluating the business rationale in relation to significant, unusual transactions and transactions entered into outside the normal course of business, and testing a sample of revenue transactions from either side of the year end to ensure that revenue had been recognised in the correct accounting period.

A further description of our responsibilities for the audit of the financial statements is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

 

Interrupt Labs Limited

Independent Auditor's Report to the Members of Interrupt Labs Limited

Use of our report

This report is made solely to the Company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

......................................
Mayulee Pinkerton CA (Senior Statutory Auditor)
For and on behalf of RSM UK Audit LLP, Statutory Auditor
 Davidson House
Forbury Square
Reading
Berkshire
RG1 3EU

6 May 2026

 

Interrupt Labs Limited

Profit and Loss Account for the Year Ended 31 December 2025

Note

2025
£

2024
£

Turnover

3

11,786,183

10,969,089

Cost of sales

 

(6,538,047)

(6,560,540)

Gross profit

 

5,248,136

4,408,549

Administrative expenses

 

(5,522,452)

(4,317,336)

Other operating income

4

924,494

1,077,013

Operating profit

6

650,178

1,168,226

Other interest receivable and similar income

7

1,074

4,696

Interest payable and similar expenses

8

(203,507)

(122,943)

   

(202,433)

(118,247)

Profit before tax

 

447,745

1,049,979

Tax on profit

11

(342,249)

(269,274)

Profit for the financial year

 

105,496

780,705

The above results were derived from continuing operations.

The Company has no recognised gains or losses for the year other than the results above.

 

Interrupt Labs Limited

(Registration number: 13427173)
Balance Sheet as at 31 December 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

12

118,203

161,010

Investments

13

7

2

 

118,210

161,012

Current assets

 

Debtors

14

6,117,861

6,234,360

Cash at bank and in hand

 

184,981

146,548

 

6,302,842

6,380,908

Creditors: Amounts falling due within one year

16

(3,093,979)

(3,032,883)

Net current assets

 

3,208,863

3,348,025

Total assets less current liabilities

 

3,327,073

3,509,037

Creditors: Amounts falling due after more than one year

16

(1,268,096)

(1,555,556)

Provisions for liabilities

17

(100,000)

(100,000)

Net assets

 

1,958,977

1,853,481

Capital and reserves

 

Called up share capital

19

78

82

Capital redemption reserve

4

-

Retained earnings

1,958,895

1,853,399

Shareholders' funds

 

1,958,977

1,853,481

Approved and authorised by the Board on 6 May 2026 and signed on its behalf by:
 

.........................................
A Last
Director

 

Interrupt Labs Limited

Statement of Changes in Equity for the Year Ended 31 December 2025

Share capital
£

Capital redemption reserve
£

Retained earnings
£

Total
£

At 1 January 2025

82

-

1,853,399

1,853,481

Profit for the year

-

-

105,496

105,496

Other capital redemption reserve movements

(4)

4

-

-

At 31 December 2025

78

4

1,958,895

1,958,977

Share capital
£

Retained earnings
£

Total
£

At 1 January 2024

82

894,164

894,246

Profit for the year

-

780,705

780,705

Purchase of own share capital

-

(327,305)

(327,305)

Sale of treasury shares

-

505,835

505,835

At 31 December 2024

82

1,853,399

1,853,481

 

Interrupt Labs Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

1

General information

The Company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Matrix House
Basing View
Basingstoke
Hampshire
RG21 4FF
England

These financial statements were authorised for issue by the Board on 6 May 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland and the Companies Act 2006'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The Company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this Company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The Company has, therefore, taken advantage of exemptions from the following disclosure requirements:

- Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures.
- Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’ - Carrying amounts, interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income.
- Section 26 ‘Share Based Payment’: Share-based payment charged to profit or loss, reconciliation of opening and closing number and weighted average exercise price of share options, how the fair value of options granted was measured, measurement and carrying amount of liabilities for cash-settled share based payments, explanation of modifications to arrangements.
- Section 33 ‘Related Party Disclosures’ - Compensation for key management personnel.

 

Interrupt Labs Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

Exemption from preparing group accounts

The financial statements contain information about Interrupt Labs Limited as an individual company and do not contain consolidated financial information as the parent of a group.
The company is exempt under section 400 of the Companies Act 2006 from the requirement to prepare consolidated financial statements as it and its subsidiary undertakings are included by full consolidation in the consolidated financial statements of its parent, IRQ Group Limited. A copy of the consolidated financial statements of IRQ Group Limited can be obtained from Companies House.

Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. In reaching this conclusion the directors have considered the working capital position of the Company and the forecast results for at least the next 12 months from the date of signing. Accordingly, the directors continue to adopt the going concern basis for accounting in preparing the financial statements.

Judgements and key sources of estimation uncertainty

The preparation of financial statements in compliance with FRS 102 requires management to make judgements, estimates and assumptions that affect the application of policies and reported profits during the financial year. Estimates and judgements are continually evaluated and are based on experience and other factors that are believed to be reasonable under current circumstances. Although these estimates are management's best knowledge of the amount, events or actions, actual results ultimately may differ from these estimates.

In the opinion of the directors there are no significant estimates and judgements requiring disclosure in the financial statements.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the Company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The Company recognises revenue when:
- the amount of revenue can be reliably measured;
- it is probable that future economic benefits will flow to the entity; and
- specific criteria have been met for each of the Company's activities.

Research and development expenditure

The company does not capitalise development expenditure, instead it is written off to profit or loss as incurred.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

 

Interrupt Labs Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

Straight line at 3 years

Office equipment

Straight line at 5 years

Leashold Improvements

Straight line at 5 years

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivables.

 

Interrupt Labs Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the Company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Provisions

Provisions are recognised when the Company has an obligation at the reporting date as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the Company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Interrupt Labs Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

3

Turnover

The analysis of the Company's revenue for the year from continuing operations is as follows:

2025
 £

2024
 £

Rendering of services

11,786,183

10,969,089

The analysis of the Company's turnover for the year by market is as follows:

2025
 £

2024
 £

UK

11,786,183

10,969,089

4

Other operating income

The analysis of the Company's other operating income for the year is as follows:

2025
 £

2024
 £

R&D tax credit

924,494

1,077,013

5

Other gains and losses

The analysis of the Company's other gains and losses for the year is as follows:

2025
 £

2024
 £

Gain/loss on disposal of property, plant and equipment

(1,157)

-

6

Operating profit

Arrived at after charging/(crediting)

2025
 £

2024
 £

Depreciation expense

80,595

84,813

Amortisation expense

-

810,673

Research and development cost

4,622,469

5,384,175

Foreign exchange losses

5,860

5,617

Loss on disposal of property, plant and equipment

1,157

-

7

Other interest receivable and similar income

2025
 £

2024
 £

Interest income on bank deposits

48

4,037

Other finance income

1,026

659

1,074

4,696

 

Interrupt Labs Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

8

Interest payable and similar expenses

2025
 £

2024
 £

Interest expense on other finance liabilities

203,507

122,943

9

Staff costs

The aggregate payroll costs (including directors' remuneration) were as follows:

2025
 £

2024
 £

Wages and salaries

6,602,228

6,368,863

Social security costs

747,802

590,672

Other short-term employee benefits

36,118

26,756

Pension costs, defined contribution scheme

451,578

378,790

Other employee expense

146,382

126,014

7,984,108

7,491,095

The average number of persons employed by the Company (including directors) during the year, analysed by category was as follows:

2025
No.

2024
No.

Administration and support

11

10

Research and development

64

60

Sales, marketing and distribution

2

2

77

72

10

Directors' remuneration

The directors' remuneration for the year was as follows:

2025
 £

2024
 £

Remuneration

526,333

453,387

Contributions paid to money purchase schemes

53,649

50,038

579,982

503,425

In respect of the highest paid director:

2025
 £

2024
 £

Remuneration

256,333

216,199

 

Interrupt Labs Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

11

Taxation

Tax charged in the income statement

2025
 £

2024
 £

Current taxation

UK corporation tax

341,088

268,048

UK corporation tax adjustment to prior periods

1,161

1,226

342,249

269,274

The tax on profit before tax for the year is the same as the standard rate of corporation tax in the UK (2024 - the same as the standard rate of corporation tax in the UK) of 25% (2024 - 25%).

The differences are reconciled below:

2025
 £

2024
 £

Profit before tax

447,745

1,049,979

Corporation tax at standard rate

111,936

262,495

Effect of revenues exempt from taxation

(110)

(50)

Effect of expense not deductible in determining taxable profit

441,770

7,719

Increase in UK and foreign current tax from adjustment for prior periods

1,161

1,226

Tax increase from effect of capital allowances and depreciation

10,702

204,232

Tax decrease arising from group relief

(223,210)

(206,348)

Total tax charge

342,249

269,274

 

Interrupt Labs Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

12

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 January 2025

325,413

325,413

Additions

46,486

46,486

Disposals

(27,339)

(27,339)

At 31 December 2025

344,560

344,560

Depreciation

At 1 January 2025

164,401

164,401

Charge for the year

80,594

80,594

Eliminated on disposal

(18,638)

(18,638)

At 31 December 2025

226,357

226,357

Carrying amount

At 31 December 2025

118,203

118,203

At 31 December 2024

161,010

161,010

 

Interrupt Labs Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

13

Investments

2025
 £

2024
 £

Investments in subsidiaries

7

2

Subsidiaries

£

Cost or valuation

At 1 January 2025

2

Additions

5

At 31 December 2025

7

Provision

Carrying amount

At 31 December 2025

7

At 31 December 2024

2

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the Company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

2025

2024

Subsidiary undertakings

Interrupt Labs (Australia) Limited

Matrix House, Basing View, Basingstoke, Hampshire, England, RG21 4FF

England

Ordinary

100%

100%

Interrupt Labs (US) Limited

Matrix House, Basing View, Basingstoke, Hampshire, England, RG21 4FF

England

Ordinary

100%

100%

Interrupt Labs US LLC

4201 Wilson Blvd, Floor 3, Arlington, VA 22203

United States of America

100%

100%

Interrupt Labs Pty Ltd

Level 21, 55 Collins Street, Melbourne, VIC 3000, Australia

Australia

100%

0%

During the period Interrupt Labs Pty Limited was formed in Australia with all share capital being issued to Interrupt Labs Limited on formation.

 

Interrupt Labs Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

Subsidiary undertakings

Interrupt Labs (Australia) Limited

The principal activity of Interrupt Labs (Australia) Limited is the provision of vulnerability research services.

Interrupt Labs (US) Limited

The principal activity of Interrupt Labs (US) Limited is that of dormancy.

Interrupt Labs US LLC

The principal activity of Interrupt Labs US LLC is the provision of vulnerability research services.

Interrupt Labs Pty Ltd

The principal activity of Interrupt Labs Pty Ltd is the provision of vulnerability research services.

14

Debtors

Note

2025
 £

2024
 £

Trade debtors

 

1,688,381

1,935,687

Amounts owed by related parties

2,780,852

2,578,586

Other debtors

 

871,062

890,726

Prepayments and accrued income

 

194,160

191,293

Income tax asset

11

583,406

638,068

   

6,117,861

6,234,360

Less non-current portion

 

(3,457,406)

(3,255,140)

Total current trade and other debtors

 

2,660,455

2,979,220


 

Note

2025
£

2024
 £

Amount owed to related parties

2,780,852

2,578,586

Other debtors

 

676,554

676,554

 

3,457,406

3,255,140

15

Cash and cash equivalents

2025
 £

2024
 £

Cash at bank

184,981

146,548

 

Interrupt Labs Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

Included within cash at bank and in hand are amounts of £3,273 (2024: £3,231) which have restricted use.

A charge is held over a nominated bank account in favour of the leasehold property as part of the Authorised
Guarantee Agreement.

A charge is held over a nominated bank account in favour of the revenue share consideration, on an accruals
basis, as part of the Sale and Purchase Agreement.

16

Creditors

Note

2025
 £

2024
 £

Due within one year

 

Loans and borrowings

20

1,045,188

748,266

Trade creditors

 

148,395

277,204

Social security and other taxes

 

720,518

656,545

Other payables

 

914,081

1,107,976

Accrued expenses

 

265,797

242,892

 

3,093,979

3,032,883

Due after one year

 

Loans and borrowings

20

1,222,222

1,555,556

Other financial liabilities

 

45,874

-

 

1,268,096

1,555,556

17

Provisions for liabilities

Dilapidations
£

At 1 January 2025

100,000

At 31 December 2025

100,000

The Company has recognised a provision of dilapidations amounting to £100,000 (2024: £100,000) as of the reporting date. The provision has been calculated based on the Company’s best estimate of the expenditure required to settle the present obligation at the reporting date, considering current market conditions. The timing and amount of the actual outflows are subject to uncertainty and may differ from the amounts provided.

 

Interrupt Labs Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

18

Pension and other schemes

Defined contribution pension scheme

The Company operates a defined contribution pension scheme. The pension cost charge for the year represents contributions payable by the Company to the scheme and amounted to £451,578 (2024: £378,790).

Contributions totalling £72,697 (2024: £69,771) were payable to the scheme at the end of the year and are included in creditors.

19

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

A Ordinary of £0.000001 each

33,000,000

33

37,000,000

37

B Ordinary of £0.000001 each

30,000,000

30

30,000,000

30

D Ordinary of £0.000001 each

15,000,000

15

15,000,000

15

78,000,000

78

82,000,000

82

20

Loans and borrowings

2025
 £

2024
 £

Non-current loans and borrowings

Bank borrowings

1,222,222

1,555,556


 

2025
 £

2024
 £

Current loans and borrowings

Bank borrowings

645,188

348,266

Other borrowings

400,000

400,000

1,045,188

748,266

Bank borrowings include a loan with an interest rate of BOE base rate + 5.2%, repayable in full in August 2030.

Other borrowings includes a loan with an interest rate of 10%, paid quarterly, with no set date of repayment.

Security on these loans is as per note 22.

 

Interrupt Labs Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

21

Share options

Until 31 October 2025, the Company operated two EMI share option schemes, both of which were open to nominated members of staff who met the eligibility criteria.

During the year, the Company issued 7,700,000 share options at a price of £0.0267795 per share. On 1 November 2025, all share options were exchanged for share options in IRQ Group Limited, the newly created parent company.
 

Note

Weighted average exercise price (pence)

Number

Outstanding at the beginning of the year

 

2.8644

9,775,000

Granted during the year

 

2.6780

7,700,000

Forfeited during the year

 

2.7986

740,000

Exercised during the year

 

-

-

Exchanged during the year

 

-

16,735,000

Outstanding at the end of the year

 

-

-

No charge has been made to operating expenses in respect of the options issued as in the opinion of the directors this charge would not be material to the financial statements.

22

Charges

Allica Financial Services Limited have a fixed and floating charge over the company's assets, registered on 2 August 2024, in relation to the bank borrowing.

HSBC UK Bank PLC have a fixed and floating charge over the company's assets in related to an overdraft facility provided.

23

Parent and ultimate parent undertaking

The Company's ultimate parent is IRQ Group Limited, incorporated in England. IRQ Group Limited is the smallest and largest group in which these financial statements are consolidated. A copy of the consolidated financial statements can be obtained from Companies House.

The directors consider there to be no ultimate controlling party.